Valmet shares fall as Biomaterials division misses expectations

Published 29/10/2025, 10:56
Valmet shares fall as Biomaterials division misses expectations

Investing.com -- Valmet shares dropped 4% on Wednesday after the company reported mixed third-quarter results with its Biomaterials division missing analyst expectations despite overall stable performance.

The company’s orders and sales were broadly in line with forecasts, while comparable EBITA (earnings before interest, taxes, and amortization) showed mixed performance across divisions. The Process division exceeded expectations, while the Biomaterials segment fell short.

In the Biomaterials division, service orders came in 4% below consensus estimates, while equipment orders were 1% below forecasts. The division’s comparable EBITA missed expectations by 7%, with margins at 9.5%, which was 80 basis points below analyst projections.

The Process Performance Solutions division, which includes automation and Neles businesses, performed better with orders 5% above consensus. This division’s comparable EBITA exceeded expectations by 16%, with margins reaching 21.9%, which was 330 basis points higher than anticipated.

Valmet maintained its full-year guidance, projecting stable sales and comparable EBITA. Market analysts currently expect a 2% decrease in sales and a 1% increase in comparable EBITA.

The company noted potential risks of further softening in service activity and mentioned ongoing uncertainty surrounding capital equipment decisions, while expecting automation markets to remain stable.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.